首頁 > 市場調查報告書 > 製藥

癌症

2030 年亞太地區神經膠質瘤治療市場預測 - 區域分析 - 按疾病、治療類型、等級和最終用戶

市場調查報告書

商品編碼

1452585

2030 年亞太地區神經膠質瘤治療市場預測 - 區域分析 - 按疾病、治療類型、等級和最終用戶

Asia Pacific Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease, Treatment Type, Grade, and End User

出版日期: 2024年01月15日 | 出版商:

The Insight Partners | 英文 97 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

亞太地區膠質瘤治療市場預計將從2022年的7.5497億美元成長到2030年的15.3888億美元。預計2022年至2030年CAGR為9.3%。

新興經濟體增加的機會推動亞太地區神經膠質瘤治療市場

巴西、俄羅斯、印度、中國和南非（金磚國家）是世界上成長最快的經濟體之一。這些國家以及其他發展中經濟體的醫療保健產業預計將在未來幾年迅速擴張。預期成長歸因於客戶需求的變化、醫療保健服務意識的提高以及人口老化的持續成長。隨著醫療保健產業的蓬勃發展，全球腦癌診斷市場可能在未來幾年顯著成長。此外，政府在醫療保健設施上的支出增加和消費者購買力有助於發展中國家醫療保健產業的成長。

由於持續的臨床研究、集中的醫療機構、高素質和積極性高的勞動力以及優良的臨床試驗設施，亞洲國家的科學能力正在不斷成長。此外，亞太地區許多國家擁有龐大且多樣化的患者庫，約 60% 的全球人口居住在該地區。亞太地區遵循美國和歐盟監管機構制定的治療指南來治療疾病，這為大量、快速招募患者提供了堅實的前景。因此，亞太地區發展中國家不斷成長的醫療保健產業為亞太地區神經膠質瘤治療市場參與者擴大業務創造了更好的機會。

亞太地區神經膠質瘤治療市場概述

亞太地區的膠質瘤治療市場預計在預測期內將以最快的CAGR成長；中國、印度和日本是該地區市場成長的三個主要貢獻者。該市場主要受到各國政府和私營部門投資增加的推動。亞洲國家和西方國家在治療開發方面合作的加強、對腦癌治療的需求不斷增加以及腦腫瘤患病率的上升是可能推動該地區亞太神經膠質瘤治療市場的幾個關鍵因素在預測期內。

中國是人口大國，醫療衛生基礎設施發達。沿海地區和農村地區社會經濟發展程度有差異。與西部農村地區相比，沿海地區的醫療資源相對發達且容易取得。與其他已開發國家和發展中國家一樣，日本也致力於加強其醫療保健系統並為其公民提供更好的醫療服務。政府正在透過各種計劃和機構鼓勵基因組測試的進步。此外，老年人口的增加和腦腫瘤發病率的飆升預計將有助於亞太地區神經膠質瘤治療市場的發展。

亞太地區膠質瘤治療市場收入及 2030 年預測（百萬美元）

亞太地區神經膠質瘤治療市場區隔

亞太地區神經膠質瘤治療市場按疾病、治療類型、等級、最終用戶和國家進行細分。

根據疾病，亞太地區神經膠質瘤治療市場分為星狀細胞瘤、少突星狀細胞瘤和少突膠質細胞瘤。 2022 年，星狀細胞瘤細分市場佔據亞太地區神經膠質瘤治療市場的最大佔有率。

依治療類型，亞太地區神經膠質瘤治療市場分為手術、化療、放射治療等。 2022年，手術細分市場在亞太地區神經膠質瘤治療市場中佔最大佔有率。

根據級別，亞太地區神經膠質瘤治療市場分為低級別和高級別。 2022 年，高層級細分市場在亞太地區神經膠質瘤治療市場中佔有更大佔有率。

根據最終用戶，亞太地區神經膠質瘤治療市場分為醫院和診所以及門診手術中心。 2022年，醫院和診所細分市場在亞太地區神經膠質瘤治療市場中佔有更大佔有率。

依國家/地區分類，亞太地區神經膠質瘤治療市場分為中國、日本、印度、韓國、澳洲和亞太地區其他地區。 2022年，中國將主導亞太地區神經膠質瘤治療市場。

Amgen Inc、Amneal Pharmaceuticals Inc、Biocon Ltd、F. Hoffmann-La Roche Ltd、Merck & Co Inc、Pfizer Inc、Sun Pharmaceutical Industries Ltd 和 Teva Pharmaceutical Industries Ltd 是亞太神經膠質瘤治療市場上的一些領先公司。

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The healthcare sectors in these countries, as well as other developing economies, are projected to expand rapidly in the coming years. The expected growth is ascribed to changes in customer demand, an increase in awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer diagnostics market is likely to grow significantly in the coming years with the proliferation of the healthcare sector. Further, increased government spending on healthcare facilities and consumer purchasing power contribute to the growth of the healthcare sector in developing countries.

Asian countries are witnessing continuous growth in their scientific capabilities, owing to the ongoing clinical research studies, centralized healthcare institutions, well-qualified and highly motivated workforces, and excellent clinical trial facilities. Further, many countries in Asia Pacific have a large and diverse patient pool, with ~60% of the global population residing in the region. Treatment guidelines prepared by regulatory bodies in the US and EU are followed in Asia Pacific for treating diseases, which offers solid prospects for significant and rapid patient recruitment. Thus, the growing healthcare sector in developing countries in Asia Pacific creates better opportunities for the Asia Pacific glioma treatment market players to expand their business.

Asia Pacific Glioma Treatment Market Overview

The Asia Pacific glioma treatment market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period; China, India, and Japan are three major contributors to the market growth in this region. The market is mainly driven by increasing investments by the government and private sectors of the respective countries. A rise in collaborations among Asian countries and Western countries for the development of treatment, increasing demand for brain cancer treatments, and rising prevalence of brain tumors are a few of the key factors that are likely to drive the Asia Pacific glioma treatment market in this region during the forecast period.

China is a country with a vast population and has flourished healthcare infrastructure. The extent of social and economic development differs between the coastal area and rural areas. In the coastal regions, healthcare resources are relatively well developed and readily available compared to the rural areas in the west. Like any other developed and developing country, Japan also focuses on strengthening its healthcare system and providing better access to health systems to its citizens. The government is encouraging advancements in genomic testing through various programs and institutes. Moreover, the increasing geriatric population and the surging prevalence of brain tumors are expected to contribute to the development of the Asia Pacific glioma treatment market.

Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Glioma Treatment Market Segmentation

The Asia Pacific glioma treatment market is segmented into disease, treatment type, grade, end user, and country.

Based on disease, the Asia Pacific glioma treatment market is segmented into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest share of the Asia Pacific glioma treatment market in 2022.

Based on treatment type, the Asia Pacific glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. The surgery segment held the largest share of the Asia Pacific glioma treatment market in 2022.

Based on grade, the Asia Pacific glioma treatment market is segmented into low grade and high grade. The high grade segment held a larger share of the Asia Pacific glioma treatment market in 2022.

Based on end user, the Asia Pacific glioma treatment market is segmented into hospital & clinics and ambulatory surgical center. The hospital & clinics segment held a larger share of the Asia Pacific glioma treatment market in 2022.

Based on country, the Asia Pacific glioma treatment market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific glioma treatment market in 2022.

Amgen Inc, Amneal Pharmaceuticals Inc, Biocon Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Pfizer Inc, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the Asia Pacific glioma treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Glioma Treatment Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Government Funding for Glioma Treatment
- 4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
- 4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
- 4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
- 4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:

5. Glioma Treatment Market - Asia Pacific Market Analysis

5.1 Asia Pacific Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

6.1 Overview
6.2 Asia Pacific Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
- 6.3.1 Overview
- 6.3.2 Astrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
- 6.4.1 Overview
- 6.4.2 Oligoastrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
- 6.5.1 Overview
- 6.5.2 Oligodendroglioma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 Asia Pacific Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
- 7.3.1 Overview
- 7.3.2 Surgery: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
- 7.4.1 Overview
- 7.4.2 Chemotherapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
- 7.5.1 Overview
- 7.5.2 Radiation Therapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

8.1 Overview
8.2 Asia Pacific Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
- 8.3.1 Overview
- 8.3.2 Low Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Grade I: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Grade II: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
- 8.4.1 Overview
- 8.4.2 High Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Grade III: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.2 Grade IV: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
- 9.3.1 Overview
- 9.3.2 Hospital & Clinics: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Glioma Treatment Market - Country Analysis

10.1 Overview
- 10.1.1 Asia Pacific Glioma Treatment Market, by Country
  - 10.1.1.1 China
    - 10.1.1.1.1 China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.1.2 China: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.1.3 China: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.1.4 China: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.1.4.1 China: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.1.4.2 China: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.1.5 China: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.2 Japan
    - 10.1.1.2.1 Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.2 Japan: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.2.3 Japan: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.2.4 Japan: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.2.4.1 Japan: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.2.4.2 Japan: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.2.5 Japan: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.3 India
    - 10.1.1.3.1 India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.2 India: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.3.3 India: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.3.4 India: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.3.4.1 India: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.3.4.2 India: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.3.5 India: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.4 South Korea
    - 10.1.1.4.1 South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.2 South Korea: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.4.3 South Korea: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.4.4 South Korea: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.4.4.1 South Korea: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.4.4.2 South Korea: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.4.5 South Korea: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.5 Australia
    - 10.1.1.5.1 Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.5.2 Australia: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.5.3 Australia: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.5.4 Australia: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.5.4.1 Australia: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.5.4.2 Australia: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.5.5 Australia: Asia Pacific Glioma Treatment Market, by End User
  - 10.1.1.6 Rest of Asia Pacific
    - 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Disease
    - 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Treatment Type
    - 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Grade
    - 10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by Low Grade
    - 10.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by High Grade
    - 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific Glioma Treatment Market, by End User

11. Asia Pacific Glioma Treatment Market Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Amgen Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Amneal Pharmaceuticals Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Biocon Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Glioma Treatment Market Segmentation
Table 2. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 12. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 13. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 21. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 22. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 23. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 24. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 25. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 26. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 27. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 28. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 29. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 30. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 31. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 32. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 33. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 34. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 35. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 36. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 37. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 38. Organic Developments Done By Companies
Table 39. Inorganic Developments Done By Companies
Table 40. Glossary of Terms, Asia Pacific glioma treatment market

List Of Figures

Figure 1. Asia Pacific Glioma Treatment Market Segmentation, By Country
Figure 2. Asia Pacific Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Asia Pacific Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Glioma Treatment Market, By Geography, 2022 ($Mn)
Figure 25. Asia Pacific Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. China: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Japan: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. India: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. South Korea: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Australia: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Rest of Asia Pacific: Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies Done by the Companies in the Market, (%)